Evidence map›Paper›PMID 26420500›Full record

ReviewEuropean radiology2016

T2 black lesions on routine knee MRI: differential considerations.

Vibhor Wadhwa, Gina Cho, Daniel Moore, Parham Pezeshk, Katherine Coyner, Avneesh Chhabra

Abstract readReview
PubMed Publisher
In one paragraph

Review in European radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vibhor WadhwaDepartment of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Gina ChoMusculoskeletal Radiology, UT Southwestern Medical Center, Dallas, TX, USA.
Daniel MooreMusculoskeletal Radiology, UT Southwestern Medical Center, Dallas, TX, USA.
Parham PezeshkMusculoskeletal Radiology, UT Southwestern Medical Center, Dallas, TX, USA.
Katherine CoynerOrthopaedic Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
Avneesh ChhabraMusculoskeletal Radiology, UT Southwestern Medical Center, Dallas, TX, USA. avneesh.chhabra@utsouthwestern.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of abnormal findings or lesions on T2-weighted fast spin-echo (FSE) magnetic resonance imaging (MRI) are hyperintense due to increased perfusion or fluid content, such as infections, tumours or synovitis. Hypointense lesions on T2-weighted images (both fat-suppressed and non-fat-suppressed) are less common and can sometimes be overlooked. Such lesions have limited differential diagnostic possibilities, and include vacuum phenomenon, loose body, tenosynovial giant cell tumour, rheumatoid arthritis, haemochromatosis, gout, amyloid, chondrocalcinosis, hydroxyapetite deposition disease, lipoma arborescens, arthrofibrosis and iatrogenic lesions. These lesions often show characteristic appearances and predilections in the knee. In this article, the authors describe the MRI features of hypointense T2 lesions on routine knee MRI and outline a systematic diagnostic approach towards their evaluation. Key Points • Hypointense lesions on T2 images (T2 Dark Lesions) encompass limited diagnostic possibilities. • T2 Dark lesions often show characteristic appearances and predilections in the knee. • A systematic diagnostic approach will help radiologists make the correct diagnosis.

Indexed as

Diagnosis, DifferentialFemaleHumansJoint DiseasesKnee JointMagnetic Resonance ImagingMaleArthrofibrosisChondrocalcinosisChondromatosisMRI kneeTenosynovial giant cell tumour

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.